Global Clinical Microbiology Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2022 –2029 |
Market Size (Base Year) |
USD 3.90 Billion |
Market Size (Forecast Year) |
USD 6.53 Billion |
CAGR |
|
Major Markets Players |
全球临床微生物学市场,按产品(仪器、试剂)、适应症(呼吸系统疾病、血液感染、胃肠道疾病、性传播疾病、泌尿道感染、牙周疾病、其他)、应用(制药应用、食品检测应用、临床应用、能源应用、化学和材料制造应用、环境应用)划分 – 行业趋势和预测至 2029 年
市场分析和规模
基于基因组测序的检测、特性检测、基于基因组测序的检测和基于质谱的检测都在临床微生物学中取得了重大进展。此外,近年来,实验室自动化和信息系统联动大数据和人工智能方法已在临床微生物学领域得到实施。在临床微生物学实验室中快速检测微生物的能力似乎对于确定真菌、细菌和分枝杆菌疾病的最佳患者管理方案至关重要。此外,临床微生物学依靠专业和专门的人员来处理和解释临床标本结果。
Data Bridge Market Research 分析,临床微生物学市场在 2021 年为 39 亿美元,到 2029 年将飙升至 65.3 亿美元,预计在 2022 年至 2029 年的预测期内复合年增长率为 6.65%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
报告指标 |
细节 |
预测期 |
2022 至 2029 年 |
基准年 |
2021 |
历史岁月 |
2020(可定制为 2014 - 2019) |
定量单位 |
收入(单位:十亿美元)、销量(单位:台)、定价(美元) |
涵盖的领域 |
产品(仪器、试剂)、适应症(呼吸系统疾病、血流感染、胃肠道疾病、性传播疾病、泌尿道感染、牙周疾病、其他)、应用(制药应用、食品检测应用、临床应用、能源应用、化学和材料制造应用、环境应用) |
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
BioMérieux (France), Danaher (US), BD (US), Abbott (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), 3M (US), Bio-Rad Laboratories (US), Bruker (US), Hologic Inc. (US), Merck KGaA (Germany), Diagnóstica Longwood SL (Chennai), Agilent Technologies Inc. (U.S), Memmert GmbH + Co.KG (Germany), Hardy Diagnostics (U.S), NEOGEN Corporation (U.S) |
Market Opportunities |
|
Market Definition
Clinical microbiology is an area of medicine that helps detect, prevent, and cure infectious diseases. It focuses on applying several assays to detect the presence of bacterial, viral, fungal, or parasitic agents as well as determine microorganism susceptibility. Typical testing approaches include direct smears and stains, cultures, molecular analysis, serological testing, and antibiotic susceptibility testing. Clinical microbiology is gaining popularity around the world as a result of improved antibiotic delivery and therapeutic effects.
Clinical Microbiology Market Dynamics
Drivers
- Increased funding and public-private investment
In the forecast period of 2022-2029, the substitution of old empirical approaches in clinical diagnostics to detect infectious pathogens such as virus, fungi, and bacteria is expected to fuel the growth of the clinical microbiology market. Increased funding and public-private investment, on the other hand, will further strengthen numerous opportunities, resulting in the clinical microbiology market's rise over the forecast period.
- Technological advancement is leading to better adaptations of end user products
With the advent of technology, molecular diagnostic tools aid in early detection and effective treatment. These enhanced molecular diagnostic methodologies imply higher sample throughput, faster turnaround times, more specificity, increased accuracy, and reaction multiplicity. NGS, molecular cartridges, real-time PCR, and PCR plus mass spectrometry are examples of sophisticated molecular diagnostic procedures that can analyse several samples in a single input. This characterization and identification of chemicals and pathogens allows for product adaption among major end users such as healthcare practitioners, pharmaceutical and biotechnology companies, and research facilities. This would create an atmosphere of global clinical microbiology market expansion.
- Prioritizing healthcare infrastructure
Governments all over the world, particularly in emerging markets, will provide the clinical biological industry with a varied range of opportunities. The rising ubiquity of diseases like malaria, influenza, tuberculosis, and HIV, as well as several other genetic efficient diseases, has created significant growth potential. Developing-country research and development measures to improve healthcare infrastructure, healthcare spending, and the availability of cost-effective clinical microbiological goods would help to boost market growth characteristics.
Opportunities
One of the major factor driving the market's growth is the rising occurrence of infectious diseases around the world. Furthermore, rising air and water pollution levels are leading to an increase in the number of people developing respiratory ailments, which drives the market. Aside from that, the incorporation of automation in clinical microbiology is boosting market growth since it allows for specimen traceability, decreases incubation delays, and increases laboratory efficiency. Furthermore, the major competitors are concentrating on adopting technology improvements in illness diagnostics, such as the use of machine learning (ML), which aids in the delivery of speedy and accurate results. This, together with the emergence of many molecular diagnostic techniques, is presenting the market with lucrative growth potential.
Restraints/Challenges
- Limited or no capitalization in developing countries
Clinical microbiological testing methods are reimbursed very little or not at all in nations like China, India, and others in the Middle East and Africa. The lack of reimbursements inhibits the adaption of clinical microbiological tests and processes when there is a large target patient group.
本临床微生物学市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关临床微生物学市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。
COVID-19 对临床微生物学市场的影响
COVID-19 疫情对临床微生物学领域产生了深远影响。该行业面临着制造和供应链方面的挑战,例如及时向最终用户交付产品以及应对该行业产品和服务的不均衡需求。缺乏熟练的实验室专业人员进行和研究诊断测试、大多数行业的运营数量减少、研究和学术机构资金不足、主要学术机构暂时关闭、供应链中断以及由于封锁而提供基本/售后服务方面的挑战,所有这些都导致临床微生物学产品对最终用户的供应减少。临床微生物学产品最常见的最终用户之一是研究机构。
近期发展
Invisible Sentinel(美国)是一家开发、制造和标记分子诊断设备的公司,用于快速、准确和可靠地检测食品和饮料中的感染和腐败生物,该公司于 2019 年被 BioMérieux(法国)收购。
全球临床微生物学市场范围
临床微生物学市场根据产品类型、应用和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。
产品
- 实验室仪器
- 微生物分析仪
- 试剂
指征
- 呼吸系统疾病
- 血流感染
- 性传播疾病
- 胃肠道疾病
- 泌尿道感染
- 牙周疾病
应用
- 制药应用
- 食品检测应用
- 临床应用
- 能源应用
- 化学和材料制造应用
- 环境应用
临床微生物学市场区域分析/见解
对临床微生物学市场进行了分析,并按国家、产品类型、应用和最终用户提供了市场规模见解和趋势,如上所述。
临床微生物学市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于传染病治疗的持续研究和政府机构的资助,北美在临床微生物学市场占据主导地位。
由于人口增长导致霍乱、伤寒和肺结核等疾病的流行,预计亚太地区将在 2022 年至 2029 年的预测期内实现最高的增长率。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和临床微生物学市场份额分析
临床微生物学市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对临床微生物学市场的关注有关。
临床微生物学市场的一些主要参与者包括:
- 生物梅里埃(法国)
- 丹纳赫(美国)
- BD(美国)
- 雅培(美国)
- F. Hoffmann-La Roche Ltd(瑞士)
- 赛默飞世尔科技公司(美国)
- QIAGEN(荷兰)
- 3M(美国)
- Bio-Rad 实验室(美国)
- 布鲁克 (美国)
- Hologic Inc.(美国)
- 默克集团(德国)
- Diagnostica Longwood SL(钦奈)
- 安捷伦科技公司(美国)
- Memmert GmbH + Co.KG(德国)
- Hardy Diagnostics(美国)
- NEOGEN 公司(美国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.